Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - bordetella bronchiseptica - misc. vaccines or anti sera - bordetella bronchiseptica vaccine-microbial active 0.0 p - immunotherapy - dog - over 3 weeks - bordetella bronchiseptica | canine cough syndrome | infectious tracheobronchitis

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - canine parainfluenza; bordetella bronchiseptica; canine adeno virus type 2 - misc. vaccines or anti sera - canine parainfluenza vaccine active 0.0 p; bordetella bronchiseptica vaccine-microbial active 0.0 p; canine adeno virus type 2 vaccine-viral active 0.0 p - immunotherapy - dog - over 8 weeks - bordetella bronchiseptica | canine adenovirus - type 2 | canine parainfluenza | canine cough syndrome | infectious tracheobronchitis

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - bordetella bronchiseptica - misc. vaccines or anti sera - bordetella bronchiseptica vaccine-microbial active 0.0 u - immunotherapy

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - bordetella bronchiseptica; canine parainfluenza virus - misc. vaccines or anti sera - bordetella bronchiseptica vaccine-microbial active 0.0 undefined; canine parainfluenza virus vaccine-viral active 0.0 undefined - immunotherapy - dog - over 4 weeks old | puppy - kennel cough | infectious tracheobronchitis

European Union - English - EMA (European Medicines Agency)

intervet international bv - live bordetella bronchiseptica bacteria strain b-c2 - immunologicals for felidae, - cats - for active immunisation of cats, of 1 month of age or older to reduce clinical signs of bordetella bronchiseptica associated upper respiratory tract disease.onset of immunity: onset of immunity was established in 8 week old cats as early as 72 hours after vaccination.duration of immunity: the duration of immunity is up to 1 year.no data on the influence of maternal antibodies on the effect of vaccination with nobivac bb for cats are available. from literature it is considered that this type of intranasal vaccine is able to induce an immune response without interference from maternally derived antibodies.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - bordetella bronchiseptica - misc. vaccines or anti sera - bordetella bronchiseptica vaccine-microbial active 1.0 cfu/u - immunotherapy

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - bordetella bronchiseptica (inactivated cell free extract; canine distemper virus - living; canine parainfluenza virus; canine adenovirus type 2 live (cav ii); canine parvo virus type 2 - parenteral liquid/solution/suspension - bordetella bronchiseptica (inactivated cell free extract vaccine-microbial active 0.0 qs dose; canine distemper virus - living vaccine-viral active 0.0 qs dose; canine parainfluenza virus vaccine-viral active 0.0 qs dose; canine adenovirus type 2 live (cav ii) vaccine-viral active 0.0 qs dose; canine parvo virus type 2 vaccine-viral active 0.0 qs dose - immunotherapy - dog | bitch | castrate | puppy - bordetella bronchiseptica | canine distemper | canine parvovirus | hepatitis :- infectious | parainfluenza virus type 2 (infections) | canine adenovirus type 1 | canine adenovirus type 2 | canine cough syndrome | infections caused by parainflu | infectious canine hepatitis | infectious tracheobronchitis | parvovirus

Philippines - English - FDA (Food And Drug Administration)

msd animal health (phils.), inc. - live avirulent vaccine (vet.) bordetella bronchiseptica culture - freeze dried powder for suspension - formulation: each 1 ml (dose) contains: bordetella bronchiseptica (bc-2 strain)...........> 1 x 10^9 cfu cfu- colony forming unit

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - bordetella bronchiseptica (inactivated cell free extract; canine adeno virus type 2; canine distemper virus - living; canine parainfluenza virus; canine parvo virus type 2; thiomersal - parenteral liquid/solution/suspension - bordetella bronchiseptica (inactivated cell free extract vaccine-microbial active 0.0 p; canine adeno virus type 2 vaccine-viral active 0.0 p; canine distemper virus - living vaccine-viral active 0.0 p; canine parainfluenza virus vaccine-viral active 0.0 p; canine parvo virus type 2 vaccine-viral active 0.0 p; thiomersal mercury other 0.1 mg/ml - immunotherapy - dog | bitch | castrate | puppy - bordetella bronchiseptica | canine distemper | canine parainfluenza | canine parvovirus | hepatitis :- infectious | canine adenovirus type 1 | canine adenovirus type 2 | canine cough syndrome | infectious canine hepatitis | infectious tracheobronchitis | parvovirus

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - bordetella bronshiseptica - misc. vaccines or anti sera - bordetella bronshiseptica active 0.0 cfu/mg - immunotherapy